01-6776. Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and Contaminants (Ranch Hand Advisory Committee); Notice of Meeting  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.

    Name of Committee: Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and Contaminants (Ranch Hand Advisory Committee).

    General Function of the Committee: To advise the Secretary and the Assistant Secretary for Health concerning its oversight of the conduct of the Ranch Hand study by the U.S. Air Force and provide scientific oversight of the Department of Veterans Affairs (VA) Army Chemical Corps Vietnam Veterans Health Study, and other studies in which the Secretary or the Assistant Secretary for Health believes involvement by the committee is desirable.

    Date and Time: The meeting will be held on April 5, 2001, 8:30 a.m. to 4:30 p.m.

    Location: Parklawn Bldg., 5600 Fishers Lane, conference room B, third floor, Rockville, MD.

    Contact: Leonard M. Schechtman, Food and Drug Administration, 5600 Fishers Lane, rm. 16-53, Rockville, MD 20857, 301-827-6696, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12560. Please call the Information Line for up-to-date information on this meeting.

    Agenda: The committee will review four research proposals and provide comments and recommendations to the U.S. Air Force. The proposals are concerned with measurements of: (1) Carotid intima-media thickness, (2) peripheral blood pressure, (3) nerve conduction velocity, and (4) archiving blood cells for future measurements of Ah receptor polymorphisms.

    Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person by March 26, 2001. Oral presentations from the public will be scheduled on April 5, 2001, between approximately 1 p.m. and 2 p.m. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person before March 26, 2001, and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation.

    Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2).

    Start Signature

    Dated: March 12, 2001.

    Linda A. Suydam,

    Senior Associate Commissioner.

    End Signature End Preamble

    [FR Doc. 01-6776 Filed 3-19-01; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Published:
03/20/2001
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
01-6776
Pages:
15726-15726 (1 pages)
PDF File:
01-6776.pdf